"Finasteride" tshuaj. Cov lus qhia thiab indications

Kev npaj "finasteride" txhawb inhibition ntawm cov enzyme uas converts testosterone rau dihydrotestosterone, ib tug txo nyob rau hauv nws cov concentration nyob rau hauv cov ntshav thiab nyob rau hauv cov ntaub so ntswg prostate. Raws li ib tug tshwm sim ntawm txo stimulating nyhuv on txoj kev loj hlob ntawm adenoma ntawm lub prostate caj pas. Cov tshuaj yuav txo tau ib tug loj ntawm ib tug loj me ntsis cov prostate, tsub kom cov zis txaus. Vim tej yam uas cov tshuaj relieved cov tsos mob ntawm benign prostatic hypertrophy hom. Yuav kom txo tau tej kev tshwm sim ntawm lub pathology yuav siv sij hawm ib tug ob peb lub hlis ntawm kev noj cov tshuaj. Cov tshuaj muaj zoo absorbability, txhais tau tias penetrates cov ntaub so ntswg thiab kua, nws muaj yog pom nyob rau hauv lub ejaculate. Lub bioavailability ntawm cov tshuaj yog yus noj kom tsawg thiab ntawm qhov kev txiav txim ntawm 80%. Tshem ntawm cov tshuaj los ntawm cov hnyuv thiab ob lub raum.

"Finasteride" txhais tau tias. Cov lus qhia. zaj lus tim khawv

Tshuaj rau prostate hyperplasia, ib tug benign xwm. Cov tshuaj zoo rau kom txhob muaj cov loj ntawm ib tug loj me ntsis cov prostate, hyperplasia yuav txo tau cov tsos mob tshwm, ua rau kom cov zis txaus. Nyiaj los rau yuav txo tau ntawm mob mob txeeb tuav tau phais (prostatectomy los yog transurethral resection) lossis hnab cug zis.

Tshuaj "finasteride". Cov lus qhia rau kev siv

Cov pom zoo txhua hnub tsib milligrams. Nyob rau hnub ntawm kev noj cov tshuaj ib zaug. Therapy yog kws kho rau ib lub caij nyoog lub sij hawm.

"Finasteride" txhais tau tias. Cov lus qhia. phiv tshua

Nyob rau lub hauv paus ntawm cov kev kho mob ntawm cov tsis zoo tsos mob cai kuj ncaw. Cov tshuaj yuav ua rau gynecomastia, angioneurotic edema, tsis libido, daim tawv nqaij ua pob ua xyua. Nyob rau hauv tej rooj plaub muaj impotence, txo phev.

"Finasteride" tshuaj. Cov lus qhia. Contraindications

Lub cuab tam yog tsis muab rau cov me nyuam thiab cov poj niam. Cov tshuaj yog ua rau cov txiv neej uas muaj npau taws me ntsis rau lub Cheebtsam, prostate cancer, obstructive uropathy. Ua ntej yuav pib txoj kev kho thiab thaum lub sij hawm nws tas kev ib lub qhov quav mus ntsuam xyuas thiab lwm yam diagnostics ntawm lwm txoj kev rau lub xub ntiag ntawm prostate cancer. Cov poj niam thaum lub sij hawm cev xeeb tub thiab nyob rau hauv lub tsev me nyuam muaj hnub nyoog yog pom zoo kom tsis txhob muaj kev sib cuag nrog lub medicament vim lub fact tias cov neeg sawv cev muaj ib tug teratogenic nyhuv.

Yog xav paub ntxiv,

Ceev faj nyob rau hauv muab tshuaj cov tshuaj "finasteride" (cov lus teb ntawm cov kws txawj paub meej tias nws) yuav tsum muaj cai nrog cov neeg mob uas raum insufficiency. Tiv thaiv lub keeb kwm ntawm ib tug loj ntim ntawm residual zis los yog ruaj txo nws tam sim no yuav tsum xav txog qhov yuav ua rau muaj obstructive uropathy hom. tseem ceeb sis txhais tau tias "finasteride" yog tsis sau tseg nyob rau hauv txoj kev xyaum ntawm kev kho mob cov khoom siv "Vafarin" "Theophylline", "Glyburide", "Digoxin" "Propanolol", "Antipyrin". Muaj tsis muaj teeb meem loj nyhuv ntawm cov tshuaj nyob rau hauv lub cytochrome P450 system. Nyob rau hauv no hais txog, muaj tsis muaj txhais tau tias ntawm lub hwj lub pharmacokinetic tsis muaj tshuaj uas kis metabolism nyob rau hauv lub siab lub hlwb. Ua ntej siv cov tshuaj "finasteride," Specialist yuav tsum ceeb toom rau tus neeg mob ntawm qhov yuav tsum tau ntev-lub sij hawm kev kho mob.